Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial
van Wilpe, S., Kloots, I.S.H., Slootbeek, P.H.J., den Brok, M., Westdorp, H., Franken, M.D., Coskunturk, M., Osinga, T., Bloemendal, H., Adema, G., Smeenk, R.J., Nagarajah, J., van Ipenburg, J., Kroeze, L.I., Ligtenberg, M.J.L., Schalken, J., Gerritsen, W.R., Mehra, N.
Published in Annals of oncology (16.09.2024)
Published in Annals of oncology (16.09.2024)
Get full text
Journal Article
Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features
van Ipenburg, J A, Naus, N C, Dubbink, H J, van Ginderdeuren, R, Missotten, G S, Paridaens, D, Verdijk, R M
Published in British journal of ophthalmology (01.10.2021)
Published in British journal of ophthalmology (01.10.2021)
Get full text
Journal Article
A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma
Ooft, M.L, van Ipenburg, J, Braunius, W.W, Stegeman, I, Wegner, I, de Bree, R, Overbeek, L.I.H, Koljenović, S, Willems, S.M
Published in Oral oncology (01.05.2016)
Published in Oral oncology (01.05.2016)
Get full text
Journal Article
LBA72 Nivolumab 3mg/kg and ipilimumab 1mg/kg (nivo3/ipi1) in molecularly selected patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Mehra, N., Van Wilpe, S., Westdorp, H., Kloots, I., Slootbeek, P., Brok, M. den, Franken, M., Coskuntürk, M., Bloemendal, H., Nagarajah, J., van Ipenburg, J., Kroeze, L., Ligtenberg, M., Schalken, J.A., Gerritsen, W.R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
2000P Combining whole blood RNA-sequencing (WB-RNA) and circulating tumor DNA (ctDNA) for the early identification of patients (pts) without clinical benefit to immune checkpoint inhibitors (ICI) in metastatic urothelial cancer (mUC)
Van Wilpe, S., Croci, D., Paske, I. te, Tolmeijer, S.H., Costa, S., Ciarloni, L., Romero, P., van Ipenburg, J., Kroeze, L., Pavan, S., Oving, I.M., Smilde, T.J., Van Voorthuizen, T., Berends, M., Franken, M., Ligtenberg, M., Hosseinian Ehrensberger, S., Mehra, N.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Ipilimumab with Nivolumab in molecular-Selected patients with castration-resistant PRostate cancer: primary analysis of the Phase 2 INSPIRE trial
van Wilpe, S, Kloots, I S H, Slootbeek, P H J, Brok, M den, Westdorp, H, Franken, M D, Coskunturk, M, Osinga, T, Bloemendal, H, Adema, G, Smeenk, R J, Nagarajah, J, van Ipenburg, J, Kroeze, L I, Ligtenberg, M J L, Schalken, J, Gerritsen, W R, Mehra, N
Published in Annals of oncology (10.09.2024)
Get full text
Published in Annals of oncology (10.09.2024)
Journal Article